Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMIT-1 metformin after TIA or minor ischemic stroke
NL-OMON26223Phase 2Recruiting
- Sponsor
- S.E. Vermeer, MD, PhD
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin in prediabetes and impaired fasting glucose (IFG) (2 arms), sponsored by S.E. Vermeer, MD, PhD. Primary endpoints: Tolerability of metformin treatment, Safety of metformin treatment and 1 more. Started Feb 2007; status: recruiting.
02
Drugs
metformin
03
Conditions
prediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on NL-OMON26223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26223.